Elagolix 200 | ELIGOLUX 200
Item requires a valid prescription
Manufactured By Steris Healthcare Pvt Ltd
Composition Elagolix Tablets 200mg
Rs 700.00
MRP Rs 1000.00
(30% OFF)
Includes all taxes
Package SIZE
( For 10 Tablet )
100% Authentic
Products
Free
Shipping*
Products
Return Policy
Description:
Elagolix 200mg Tablet is a prescription medicine used to manage moderate to severe pain associated with endometriosis, including painful periods, non-menstrual pelvic pain, and pain during intercourse. Elagolix 200mg Tablet works by lowering estrogen levels through a hormone-blocking mechanism (GnRH receptor antagonism), which reduces the hormonal stimulation that fuels endometriosis-related pain. Elagolix 200mg Tablet is taken orally, typically twice daily, and treatment duration is limited based on dose to reduce bone density risks.
What Is Elagolix 200mg Tablet?
Elagolix 200mg Tablet is an oral prescription medicine belonging to the class of drugs called GnRH (gonadotropin-releasing hormone) receptor antagonists, used specifically for the management of moderate to severe pain associated with endometriosis in women of reproductive age. Elagolix 200mg Tablet works differently from older hormonal therapies — instead of first stimulating hormone release before suppressing it, Elagolix 200mg Tablet directly and immediately blocks GnRH receptors, offering more predictable, dose-dependent control over estrogen suppression.
Elagolix 200mg Tablet is manufactured and supplied by Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO certified Indian pharmaceutical company, and is typically prescribed by gynecologists managing endometriosis-related pain in patients who have not responded adequately to other treatments.
How Does Elagolix 200mg Work?
Endometriosis pain is largely driven by estrogen, which stimulates the growth and activity of endometrial-like tissue outside the uterus. Elagolix 200mg Tablet targets this hormonal pathway through the following steps:
- Step 1 — GnRH receptor blockade: Elagolix 200mg Tablet binds directly to GnRH receptors in the pituitary gland, blocking the natural GnRH hormone from attaching.
- Step 2 — Reduced LH and FSH release: By blocking these receptors, Elagolix 200mg Tablet reduces the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.
- Step 3 — Lower estrogen production: With reduced LH and FSH signalling, the ovaries produce less estrogen, directly lowering circulating estrogen levels in the body.
- Step 4 — Reduced pain stimulation: Because endometrial-like tissue growth and inflammation are estrogen-dependent, Elagolix 200mg Tablet's estrogen-lowering effect helps reduce the pain signals associated with endometriosis, including menstrual and non-menstrual pelvic pain.
Because Elagolix 200mg Tablet's effect is dose-dependent, the 200mg twice-daily dose produces a greater degree of estrogen suppression compared to lower doses, which is why treatment duration and monitoring differ by dose strength.
Clinical Indications
| Indication | Details |
|---|---|
| Primary use | Moderate to severe pain associated with endometriosis |
| Symptom types addressed | Dysmenorrhea (painful periods), non-menstrual pelvic pain, dyspareunia (pain during intercourse) |
| Patient profile | Women of reproductive age diagnosed with endometriosis |
| Not indicated for | Use during pregnancy or in women trying to conceive during therapy |
| Combine with | Regular gynecological monitoring, especially of bone mineral density during extended use |
Dosage Guidelines
| Parameter | Recommendation |
|---|---|
| Standard dose | As prescribed by the physician, generally taken twice daily |
| Administration | Taken orally, with or without food, at consistent times each day |
| Treatment duration (200mg dose) | Limited duration recommended due to bone mineral density considerations — as advised by your doctor |
| Missed dose | Take as soon as remembered; if close to the next dose, skip the missed one — do not double up |
| Contraception requirement | Non-hormonal contraception is generally recommended during treatment, as Elagolix 200mg Tablet is not a contraceptive |
| Monitoring | Periodic bone density assessment may be recommended for extended courses |
Key Benefits of Elagolix 200mg Tablet
- Significantly reduces endometriosis-associated pain, including menstrual pain, pelvic pain, and pain during intercourse
- Oral, non-injectable option — unlike some older hormone-suppressing therapies that require injections
- Rapid onset of receptor blockade, offering more predictable hormone suppression compared to agonist-based therapies
- Dose-flexible approach, allowing physicians to balance symptom control against long-term bone health considerations
- Non-surgical management option for women seeking to avoid or delay surgical intervention for endometriosis
- Improves quality of life for many patients by reducing chronic pelvic pain that interferes with daily activities
Precautions Before Taking Elagolix 200mg Tablet
- Elagolix 200mg Tablet should not be used during pregnancy, as it can cause fetal harm — a pregnancy test is generally recommended before starting therapy
- Non-hormonal contraception should be used during treatment unless your doctor advises otherwise, since Elagolix 200mg Tablet does not prevent pregnancy
- Inform your doctor if you have osteoporosis or risk factors for bone loss, as prolonged use of Elagolix 200mg Tablet, particularly at higher doses, may reduce bone mineral density
- Use with caution in patients with liver impairment, as Elagolix 200mg Tablet is metabolized in the liver
- Inform your doctor about any history of depression, mood changes, or suicidal thoughts, as hormonal changes during treatment may affect mood in some patients
- Discuss all other medicines and supplements with your doctor, as certain drugs can interact with Elagolix 200mg Tablet's metabolism
- Treatment duration limits should be followed strictly as advised by your physician, especially at the 200mg twice-daily dose
Side Effects of Elagolix 200mg Tablet
Common Side Effects
- Hot flashes or night sweats
- Headache
- Nausea
- Irregular or unpredictable menstrual bleeding
- Fatigue
- Mood changes, including anxiety
Serious Side Effects
- Signs of significant bone density loss, especially with long-term use
- Severe mood changes, including new or worsening depression or suicidal thoughts
- Signs of liver problems: yellowing of the skin or eyes, dark urine, severe abdominal pain
- Signs of an allergic reaction: swelling of the face, lips, or throat; difficulty breathing
- Unusual or heavy vaginal bleeding
Can Elagolix 200 Stop Periods?
Elagolix 200mg Tablet does not eliminate menstruation for all patients, but many women experience lighter, irregular, or occasionally absent periods while on therapy due to the estrogen-lowering effect of Elagolix 200mg Tablet. This change in bleeding pattern is generally considered an expected effect of hormone suppression rather than a guaranteed outcome, and menstrual patterns typically return to baseline after stopping treatment. Any unusual, heavy, or prolonged bleeding while on Elagolix 200mg Tablet should be reported to your doctor.
Elagolix 200mg Tablet vs Other Endometriosis Pain Treatments
| Feature | Elagolix 200mg Tablet | GnRH Agonists (e.g., Leuprolide) | NSAIDs |
|---|---|---|---|
| Mechanism | Direct GnRH receptor blockade | Initial hormone surge, then suppression | Pain and inflammation relief only |
| Route | Oral | Injectable | Oral |
| Onset of hormone suppression | Rapid, dose-dependent | Delayed (initial flare before suppression) | Not hormone-related |
| Addresses root hormonal cause | Yes | Yes | No — symptomatic relief only |
| Bone density consideration | Yes, dose- and duration-dependent | Yes, similar consideration | Not applicable |
Key Statistics
| Statistic | Data Point | Source |
|---|---|---|
| Endometriosis prevalence | Affects a significant proportion of women of reproductive age globally | [To be verified with WHO/peer-reviewed source before publish] |
| Pain reduction with GnRH antagonist therapy | Clinical trials report meaningful reduction in dysmenorrhea and pelvic pain scores | [To be verified with peer-reviewed clinical trial source before publish] |
| Bone mineral density monitoring | Recommended for extended-duration GnRH antagonist therapy | [To be verified with regulatory/clinical guideline source before publish] |
Frequently Asked Questions
Q1. Can Elagolix 200 stop periods?
Elagolix 200mg Tablet does not guarantee a complete stop to periods, but many women experience lighter, irregular, or occasionally absent menstrual bleeding while on treatment due to reduced estrogen levels. This effect varies between individuals and typically reverses after stopping Elagolix 200mg Tablet.
Q2. What is the use of Elagolix 200 mg tablet? Elagolix 200mg Tablet is used to manage moderate to severe pain associated with endometriosis, including painful periods, non-menstrual pelvic pain, and pain during intercourse. It works by lowering estrogen levels to reduce the hormonal stimulation that drives endometriosis-related pain.
Q3. How long is the treatment for Elagolix?
Treatment duration for Elagolix 200mg Tablet depends on the dose and is generally limited to reduce the risk of bone mineral density loss with prolonged use. Your doctor will determine the appropriate treatment length based on symptom severity, response to therapy, and bone health monitoring.
Q4. Is Elagolix a painkiller?
Elagolix 200mg Tablet is not a traditional painkiller like an NSAID or analgesic — instead, it works by addressing the underlying hormonal cause of endometriosis pain through estrogen suppression. By reducing estrogen-driven inflammation and tissue activity, Elagolix 200mg Tablet indirectly reduces pain over the course of treatment, rather than providing immediate symptomatic pain relief.
Q5. Can Elagolix 200mg Tablet be taken with food?
Yes, Elagolix 200mg Tablet can generally be taken with or without food, though it should be taken at consistent times each day for the most predictable effect.
Q6. Does Elagolix 200mg Tablet affect fertility?
Elagolix 200mg Tablet is not a contraceptive and does not reliably prevent pregnancy, so non-hormonal contraception is generally recommended during treatment. Discuss fertility planning with your doctor before and after therapy.
Conclusion
Elagolix 200mg Tablet offers a targeted, oral treatment option for women experiencing moderate to severe pain associated with endometriosis. By directly blocking GnRH receptors and reducing estrogen production, Elagolix 200mg Tablet addresses the hormonal root cause of endometriosis-related pain rather than simply masking symptoms. While Elagolix 200mg Tablet can meaningfully improve quality of life for many patients, treatment duration and dosing must be carefully managed — particularly regarding bone mineral density — under the close supervision of a gynecologist. Anyone considering Elagolix 200mg Tablet should have a detailed conversation with their doctor about symptom severity, treatment goals, contraception needs, and bone health before starting therapy.
Prescription only – consult your doctor.
Brand name: ELIGOLUX 200 (STERIS HEALTHCARE PVT LTD)
Composition Name: Elagolix Tablets 200mg
Pack size: Strip of 10 tablets
Marketed By: Steris Healthcare Pvt Ltd
Regulatory standard: WHO-GMP certified
Schedule: Valid Prescription Required (prescription only)